When inspecting fasting triglyceride levels at the first timepoint after initiating MAD therapy, low free carnitine showcased a 36.56% triglyceride level increase that was significantly different ( p = 0.0386) compared to 1.37% triglyceride level decrease in the normal free carnitine group
Al-Taiar, A., Rahman, A., Al-Sabah, R., Shaban, L
Read our new blog, Beyond Diabetes and Obesity: The Expansion of GLP-1 Medications, to learn more about recent approvals and ongoing research to expand their use: To view or add a comment, sign in More Relevant Posts Starting in early 2026, California will sell a state-branded, biosimilar insulin for no more than $11 per pen, or $55 for a five-pack
Wrapping practical advice into daily habits Small, consistent habits make the biggest difference: prefer powders or capsules if odor worries you, keep bottles sealed and cool, choose single-dose formats for liquids, and report suspect products
Researchers from the University of Aberdeen and the Observational and Pragmatic Research Institute in the United Kingdom recently examined how these medications impact asthma control in people with obesity
